The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma
Open accessAbstract
Primary aldosteronism is the most common form of secondary hypertension. Somatic mutations in KCNJ5, ATP1A1, ATP2B3, and CACNA1D have been described in aldosterone-producing adenomas (APAs). Our aim was to investigate the prevalence of somatic mutations in these genes in unselected patients with APA (n=474), collected through the European Network for the Study of Adrenal Tumors. Correlations with clinical and biochemical parameters were first analyzed in a subset of 199 patients from a single center and then replicated in 2 additional centers. Somatic heterozygous KCNJ5 mutations were present in 38% (180/474) of APAs, whereas ATP1A1 mutations were found in 5.3% (25/474) and ATP2B3 mutations in 1.7% (8/474) of APAs. Previously reported somatic CACNA1D mutations as well as 10 novel CACNA1D mutations were identified in 44 of 474 (9.3%) APAs. There was no difference in the cellular composition of APAs or in CYP11B2, CYP11B1, KCNJ5, CACNA1D, or ATP1A1 gene expression in APAs across genotypes. Patients with KCNJ5 mutations were more frequently female, diagnosed younger, and with higher minimal plasma potassium concentrations compared with CACNA1D mutation carriers or noncarriers. CACNA1D mutations were associated with smaller adenomas. These associations were largely dependent on the population structure of the different centers. In conclusion, recurrent somatic mutations were identified in 54% of APAs. Young women with APAs are more likely to be KCNJ5 mutation carriers; identification of specific characteristics or surrogate biomarkers of mutation status may lead to targeted treatment options.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationK + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C. J., Ji, W., Cho, Y., Patel, A. P., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 999
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationPitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationSomatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544
Cited by
Sorted by citations
Zamponi, G. W., Striessnig, J., Koschak, A., & DOLPHIN, A. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009654 · Cited by 1,158
Diagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 377
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Mutations in KCNJ5, CACNA1H, ATP1A1, ATP2B3, and CACNA1D account for approximately 50% of aldosteroneproducing adrenal adenomas (159) in patients from Europe; this is likely to be higher in Asian patients.”
BackgroundWilliams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Nishimoto, K., Tomlins, S. A., Kuick, R. D., Cani, A. K., Giordano, T. J., Hovelson, D. H., Liu, C., Sanjanwala, A. R., Edwards, M. A., Gómez-Sánchez, C. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505529112 · Cited by 337
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 333
Vaidya, A., Mulatero, P., Baudrand, R. F., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 314
Self-citationSteroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Self-citationCLCN2 chloride channel mutations in familial hyperaldosteronism type II
Scholl, U. I., Stölting, G., Schewe, J., Thiel, A., Tan, H., Nelson-Williams, C. J., Vichot, A. A., Jin, S. C., Loring, E. C., Untiet, V., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0048-5 · Cited by 275
Lenzini, L., Rossitto, G., Maiolino, G., Letizia, C., Funder, J. W., & Rossi, G. P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2149 · Cited by 224
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism
Omata, K., Satoh, F., Morimoto, R., Ito, S., Yamazaki, Y., Nakamura, Y., Anand, S. K., Guo, Z., Stowasser, M., Sasano, H., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11086 · Cited by 209
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans
Nanba, K., Omata, K., Else, T., Beck, P. C. C., Nanba, A. T., Turcu, A. F., Miller, B. S., Giordano, T. J., Tomlins, S. A., & Rainey, W. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01004 · Cited by 181
Activating mutations in CTNNB1 in aldosterone producing adenomas
Åkerström, T., Maharjan, R., Willenberg, H. S., Cupisti, K., Ip, J. C. Y., Moser, A., Stalberg, P. L. H., Robinson, B. G., Iwen, K. A., Dralle, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19546 · Cited by 178
Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks
Nanba, K., Omata, K., Gómez-Sánchez, C. E., Stratakis, C. A., Demidowich, A. P., Suzuki, M., Thompson, L. D. �., Cohen, D. L., Luther, J. M., Gellert, L. L., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12070 · Cited by 175
Development of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174
CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism
Daniil, G., Fernandes-Rosa, F. L., Chemin, J., Blesneac, I., Beltrand, J., Polak, M., Jeunemaı̂tre, X., Boulkroun, S., Amar, L., Strom, T. M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.002 · Cited by 171
Self-citationGenotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas
Williams, T. A., Peitzsch, M., Dietz, A., Dekkers, T., Bidlingmaier, M., Riester, A., Treitl, M., Rhayem, Y., Beuschlein, F., Lenders, J. W. M., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06186 · Cited by 167
Self-citationStowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 162
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma
Sousa, K. D., Boulkroun, S., Baron, S., Nanba, K., Wack, M., Rainey, W. E., Rocha, A., Giscos-Douriez, I., Méatchi, T., Amar, L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14177 · Cited by 155
Self-citationClinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151
Scholl, U. I., Healy, J. M., Thiel, A., Fonseca, A. L., Brown, T. C., Kunstman, J. W., Horne, M. J., Dietrich, D., Riemer, J. C., Kücükköylü, S., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12873 · Cited by 150
Pathogenesis and treatment of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0382-4 · Cited by 159
Self-citationThe Plasma Membrane Calcium ATP ases and Their Role as Major New Players in Human Disease
Stafford, N., Wilson, C., Oceandy, D., Neyses, L., & Cartwright, E. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00028.2016 · Cited by 153
Omata, K., Anand, S. K., Hovelson, D. H., Liu, C., Yamazaki, Y., Nakamura, Y., Ito, S., Satoh, F., Sasano, H., Rainey, W. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00134 · Cited by 142
Monticone, S., Castellano, I., Versace, K., Lucatello, B. G., Veglio, F., Gómez-Sánchez, C. E., Williams, T. A., & Mulatero, P. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.022 · Cited by 141
Self-citationVelema, M. S., Dekkers, T., Hermus, A. R., Timmers, H. J. L. M., Lenders, J. W. M., Groenewoud, H., Kool, L. J. S., Langenhuijsen, J. F., Prejbisz, A., van der Wilt, G. J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01442 · Cited by 141
Wu, V., Hu, Y., Er, L., Yen, R., Chang, C., Chang, Y., Lu, C., Chang, C., Lin, J., Lin, Y., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2017.06.004 · Cited by 122
Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing Adenoma
Nanba, K., Blinder, A., Rege, J., Hattangady, N. G., Else, T., Liu, C., Tomlins, S. A., Vats, P., Kumar‐Sinha, C., Giordano, T. J., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14349 · Cited by 121
Ghorayeb, N. E., Mazzuco, T. L., Bourdeau, I., Mailhot, J., Zhu, P. S., Thérasse, É., & Lacroix, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3915 · Cited by 110
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00072 · Cited by 109
Piaditis, G. P., Markou, Α., Papanastasiou, L., Androulakis, I. I., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0537 · Cited by 101
Wu, V., Huang, K., Peng, K., Tsai, Y., Wu, C., Wang, S., Yang, S., Lin, L., Chang, C., Lin, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep11396 · Cited by 98
Genetic Causes of Functional Adrenocortical Adenomas
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00189 · Cited by 107
Self-citationMolecular Heterogeneity in Aldosterone-Producing Adenomas
Nanba, K., Chen, A., Omata, K., Vinco, M., Giordano, T. J., Else, T., Hammer, G. D., Tomlins, S. A., & Rainey, W. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3239 · Cited by 97
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
Wu, V., Wang, S., Chueh, S., Yang, S., Huang, K., Lin, Y., Wang, J., Connolly, R., Hu, Y., Gómez-Sánchez, C. E., et al. (2017) · Scientific Reports · doi:10.1038/srep39121 · Cited by 97
The Influence of Na+, K+-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence
Kinoshita, P. F., Leite, J. A., Orellana, A. M., Vasconcelos, A. R., Quintas, L. E. M., Kawamoto, E. M., & Scavone, C. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00195 · Cited by 93
Zhou, J., Azizan, E. A. B. A., Cabrera, C., Fernandes-Rosa, F. L., Boulkroun, S., Argentesi, G., Cottrell, E., Amar, L., Wu, X., O’Toole, S. M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00906-y · Cited by 96
Self-citationNovel somatic mutations and distinct molecular signature in aldosterone-producing adenomas
Åkerström, T., Willenberg, H. S., Cupisti, K., Ip, J. C. Y., Backman, S., Moser, A., Maharjan, R., Robinson, B. G., Iwen, K. A., Dralle, H., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0321 · Cited by 85
Cav1.3 (CACNA1D) L‐type Ca2+ channel dysfunction in CNS disorders
Pinggera, A., & Striessnig, J. (2016) · The Journal of Physiology · doi:10.1113/jp270672 · Cited by 81
Comprehensive Analysis of Steroid Biomarkers for Guiding Primary Aldosteronism Subtyping
Turcu, A. F., Wannachalee, T., Tsodikov, A. D., Nanba, A. T., Ren, J., Shields, J. J., O’Day, P., Giacherio, D. A., Rainey, W. E., & Auchus, R. J. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13866 · Cited by 78
Scholl, U. I., Abriola, L., Zhang, C., Reimer, E. N., Plummer, M. S., Kazmierczak, B. I., Zhang, J., Hoyer, D., Merkel, J. S., Wang, W., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91733 · Cited by 78
Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients
Nanba, K., Yamazaki, Y., Bick, N. R., Onodera, K., Tezuka, Y., Omata, K., Ono, Y., Blinder, A., Tomlins, S. A., Rainey, W. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa595 · Cited by 75
Tauber, P., Aichinger, B., Christ, C. B., Stindl, J., Rhayem, Y., Beuschlein, F., Warth, R., & Bandulik, S. (2016) · Endocrinology · doi:10.1210/en.2015-2029 · Cited by 72
Self-citationMonticone, S., Satoh, F., Viola, A., Fischer, E., Vonend, O., Bernini, G. P., Lucatello, B. G., Quinkler, M. O., Ronconi, V., Morimoto, R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2345 · Cited by 70
Self-citationTezuka, Y., Yamazaki, Y., Kitada, M., Morimoto, R., Kudo, M., Seiji, K., Takase, K., Kawasaki, Y., Mitsuzuka, K., Ito, A., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12064 · Cited by 70
Kitamoto, T., Suematsu, S., Yamazaki, Y., Nakamura, Y., Sasano, H., Matsuzawa, Y., Saito, J., Omura, M., & Nishikawa, T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3284 · Cited by 70
An update on novel mechanisms of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0597 · Cited by 69
Self-citationVilela, L. A. P., Rassi-Cruz, M., Guimaraes, A. G., Moises, C., Freitas, T. C., Alencar, N., Petenuci, J., Goldbaum, T. S., Maciel, A. A. W., Pereira, M. A. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00531 · Cited by 69
Wannachalee, T., Zhao, L., Nanba, K., Nanba, A. T., Shields, J. J., Rainey, W. E., Auchus, R. J., & Turcu, A. F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01182 · Cited by 70
Adrenocortical tumorigenesis: Lessons from genetics
Kamilaris, C. D. C., Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101428 · Cited by 71
De novo CACAN1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism
Ortner, N. J., Kaserer, T., Copeland, J. N., & Striessnig, J. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02418-w · Cited by 68
Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na+/K+-ATPase
Stindl, J., Tauber, P., Sterner, C. W., Tegtmeier, I., Warth, R., & Bandulik, S. (2015) · Endocrinology · doi:10.1210/en.2015-1466 · Cited by 67
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma
Fernandes-Rosa, F. L., Giscos-Douriez, I., Amar, L., Gómez-Sánchez, C. E., Méatchi, T., Boulkroun, S., & Zennaro, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05993 · Cited by 70
Self-citationWang, B., Li, X., Zhang, X., Ma, X., Chen, L., Zhang, Y., Lyu, X., Tang, Y., Huang, Q., Gao, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000708 · Cited by 66
Aging and Adrenal Aldosterone Production
Nanba, K., Vaidya, A., & Rainey, W. E. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10391 · Cited by 69
Diagnostic approach to low‐renin hypertension
Monticone, S., Losano, I., Tetti, M., Buffolo, F., Veglio, F., & Mulatero, P. (2018) · Clinical Endocrinology · doi:10.1111/cen.13741 · Cited by 66
Self-citationJuhlin, C. C., Bertherat, J. Y., Giordano, T. J., Hammer, G. D., Sasano, H., & Mete, Ö. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09667-0 · Cited by 63
Wu, X., Azizan, E. A. B. A., Goodchild, E., Garg, S., Hagiyama, M., Cabrera, C., Fernandes-Rosa, F. L., Boulkroun, S., Kuan, J. L., Tiang, Z., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01403-0 · Cited by 63
Self-citationAldosterone-Producing Cell Clusters in Normal and Pathological States
Omata, K., Tomlins, S. A., & Rainey, W. E. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122394 · Cited by 61
Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After Adrenalectomy
Tetti, M., Brüdgam, D., Burrello, J., Udager, A. M., Riester, A., Knösel, T., Beuschlein, F., Rainey, W. E., Reincke, M., & Williams, T. A. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22281 · Cited by 56
Self-citationGenetics of Aldosterone-Producing Adenoma in Korean Patients
Hong, A. R., Kim, J. H., Song, Y. S., Lee, K. E., Seo, S. H., Seong, M., Shin, C. S., Kim, S. W., & Kim, S. Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147590 · Cited by 56
Genetic causes of primary aldosteronism
Seidel, E., Schewe, J., & Scholl, U. I. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0337-9 · Cited by 56
GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism
Monticone, S., Buffolo, F., Tetti, M., Veglio, F., Pasini, B., & Mulatero, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0946 · Cited by 54
Self-citationHofer, N. T., Tuluc, P., Ortner, N. J., Nikonishyna, Y. V., Fernándes-Quintero, M. L., Liedl, K. R., Flucher, B. E., Cox, H. S., & Striessnig, J. (2020) · Molecular Autism · doi:10.1186/s13229-019-0310-4 · Cited by 54
Identification of risk loci for primary aldosteronism in genome-wide association studies
Floch, É. L., Cosentino, T., Larsen, C. K., Beuschlein, F., Reincke, M., Amar, L., Rossi, G. P., Sousa, K. D., Baron, S., Chantalat, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32896-8 · Cited by 57
Self-citationSomatic and inherited mutations in primary aldosteronism
Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0035 · Cited by 54
Self-citationAldosterone-Producing Adenomas
Tan, G. C., Negro, G., Pinggera, A., Laim, N. M. S. T., Rose, I. M., Ceral, J., Ryška, A., Chin, L. K., Kamaruddin, N. A., Mokhtar, N. M., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09057 · Cited by 54
NovelKCNJ5Mutations in Sporadic Aldosterone-Producing Adenoma Reduce Kir3.4 Membrane Abundance
Cheng, C., Sung, C., Wu, S.-T., Lin, Y.-C., Sytwu, H., Huang, C.-L., & Lin, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3009 · Cited by 52
In situ metabolomics of aldosterone-producing adenomas
Murakami, M., Rhayem, Y., Kunzke, T., Sun, N., Feuchtinger, A., Ludwig, P., Strom, T. M., Gómez-Sánchez, C. E., Knösel, T., Kirchner, T., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130356 · Cited by 52
Self-citationIdentification of Somatic Mutations in CLCN2 in Aldosterone-Producing Adenomas
Rege, J., Nanba, K., Blinder, A., Plaska, S. W., Udager, A. M., Vats, P., Kumar‐Sinha, C., Giordano, T. J., Rainey, W. E., & Else, T. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa123 · Cited by 53
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51
Pathophysiology and histopathology of primary aldosteronism
Williams, T. A., & Reincke, M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.10.002 · Cited by 52
Self-citationARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions
Mulatero, P., Schiavi, F., Williams, T. A., Monticone, S., Barbon, G., Opocher, G., & Fallo, F. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.98 · Cited by 50
Self-citationIs There a Role for Genomics in the Management of Hypertension?
Burrello, J., Monticone, S., Buffolo, F., Tetti, M., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061131 · Cited by 50
Self-citationNanba, K., & Rainey, W. E. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0031 · Cited by 50
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling
Monticone, S., Else, T., Mulatero, P., Williams, T. A., & Rainey, W. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.015 · Cited by 49
Self-citationGenetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 52
Disordered CYP11B2 Expression in Primary Aldosteronism
Gómez-Sánchez, C. E., Kuppusamy, M., Reincke, M., & Williams, T. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122238 · Cited by 48
Self-citationT-Type Calcium Channel: A Privileged Gate for Calcium Entry and Control of Adrenal Steroidogenesis
Rossier, M. F. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00043 · Cited by 47
Yang, Y., Gómez-Sánchez, C. E., Jaquin, D., Prada, E. T. A., Meyer, L. S., Knösel, T., Schneider, H., Beuschlein, F., Reincke, M., & Williams, T. A. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13476 · Cited by 47
Self-citationKCNJ5 Mutations Are the Most Frequent Genetic Alteration in Primary Aldosteronism
Williams, T. A., Monticone, S., & Mulatero, P. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04636 · Cited by 47
Self-citationDiseases caused by mutations in the Na + /K + pump α1 gene ATP1A1
Biondo, E. D., Spontarelli, K., Ababioh, G., Méndez, L., & Artigas, P. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00059.2021 · Cited by 46
Ono, Y., Yamazaki, Y., Omata, K., Else, T., Tomlins, S. A., Rhayem, Y., Williams, T. A., Reincke, M., Carling, T., Monticone, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz235 · Cited by 46
Self-citationGenetic and Genomic Mechanisms of Primary Aldosteronism
Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.05.005 · Cited by 43
Self-citationThe Sexually Dimorphic Adrenal Cortex: Implications for Adrenal Disease
Lyraki, R., & Schedl, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094889 · Cited by 39
Duparc, C., Moreau, L., Dzib, J. F. G., Boyer, H.-G., Nomigni, M. T., Boutelet, I., Boulkroun, S., Mukai, K., Benecke, A., Amar, L., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3660 · Cited by 42
Self-citationLGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal
Shaikh, L. H., Zhou, J., Teo, A. E. D., Garg, S., Neogi, S. G., Figg, N. L., Yeo, G. S. H., Yu, H., Maguire, J. J., Zhao, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1734 · Cited by 41
Akasaka, H., Yamamoto, K. I., Rakugi, H., Nagasawa, M., Nakamaru, R., Ichijo, T., Takeda, Y., Kurihara, I., Katabami, T., Tsuiki, M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13006 · Cited by 41
Pharmacological treatment of aldosterone excess
Deinum, J., Riksen, N. P., & Lenders, J. W. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.006 · Cited by 41
Voltage-gated calcium channels in the human adrenal and primary aldosteronism
Felizola, S. J. A., Maekawa, T., Nakamura, Y., Satoh, F., Ono, Y., Kikuchi, K., Aritomi, S., Ikeda, K., Yoshimura, M., Tojo, K., et al. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.08.012 · Cited by 40
Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues
Zhou, J., Lam, B., Neogi, S. G., Yeo, G. S. H., Azizan, E. A. B. A., & Brown, M. J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08033 · Cited by 40
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Prada, E. T. A., Burrello, J., Reincke, M., & Williams, T. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10111 · Cited by 39
Self-citationRole of the endothelium and blood stasis in the development of varicose veins.
Michiels, C., Bouaziz, N., & Remacle, J. (2002) · PubMed · Cited by 38
Two-pore domain potassium channels in the adrenal cortex.
Bandulik, S., Tauber, P., Lalli, E., Barhanin, J., & Warth, R. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1628-6 · Cited by 38
Regulation of aldosterone secretion by Cav1.3
Xie, C. B., Shaikh, L. H., Garg, S., Tanriver, G., Teo, A. E. D., Zhou, J., Maniero, C., Zhao, W., Kang, S., Silverman, R. B., et al. (2016) · Scientific Reports · doi:10.1038/srep24697 · Cited by 42
Genetics of Adrenocortical Development and Tumors
Lodish, M. B. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.007 · Cited by 37
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 35
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations
Okamura, T., Nakajima, Y., Katano-Toki, A., Horiguchi, K., Matsumoto, S., Yoshino, S., Yamada, E., Tomaru, T., Ishii, S., Saito, T., et al. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0243 · Cited by 36
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 36
The potential of targeting CYP11B
Bernhardt, R. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151873 · Cited by 35
Metadata
- Authors
- Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., Mantero, F., Cicala, M.-V., Quinkler, M., Fallo, F., Allolio, B., Bernini, G., Maccario, M., Giacchetti, G., Jeunemaitre, X., Mulatero, P., Reincke, M., & Zennaro, M.-C.
- Affiliations
- Inserm (FR)
- From the INSERM, UMRS_970, Paris Cardiovascular Research Center, Paris, France (F.L.F.-R., S.B., L.A., T.M., X.J., M.-C.Z.); University Paris Descartes, Sorbonne Paris Cité, Paris, France (F.L.F.-R., S.B., L.A., T.M., X.J., M.-C.Z.); Service de Génétique (F.L.F.-R., X.J., M.-C.Z.), Unité Hypertension artérielle (L.A.), and Service d’Anatomie Pathologique (T.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France; Divisions of Internal Medicine and Hypertension,...
- ORCID
- Venue
- Hypertension
- Published
- 2014-08
- Volume
- 64
- Issue
- 2
- Pages
- 354-361
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111582520
- Cited by
- 310
- References
- 30
- Citations by year
- 2026: 21 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 16 · 2021: 28 · 2020: 27 · 2019: 33 · 2018: 25 · 2017: 31 · 2016: 34 · 2015: 33 · 2014: 12
- FWCI
- 29.40
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone-producing adenoma, primary aldosteronism, somatic mutations, KCNJ5, ATP1A1, ATP2B3, CACNA1D, secondary hypertension, plasma potassium, adenoma size, mutation prevalence, genetic spectrum, clinical correlates
- MeSH terms
- Sodium-Potassium-Exchanging ATPase, Adrenal Cortex Neoplasms, Adult, Age Factors, Aldosterone, Female, Humans, Hyperaldosteronism, Male, Middle Aged, Mutation, Potassium, Sex Factors, Adrenocortical Adenoma, Genetic Predisposition to Disease, Calcium Channels, L-Type, G Protein-Coupled Inwardly-Rectifying Potassium Channels, Plasma Membrane Calcium-Transporting ATPases, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
